Bruno Herculano

Bruno Herculano

Auto-generated profile, based on publicly available information

Bruno Herculano

Department of Neurology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2013 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
BHBruno Herculano
Bruno Herculano
MTMinami Tamura
Minami Tamura
AOAyaka Ohba
Ayaka Ohba
MSMayu Shimatani
Mayu Shimatani
NKNatsumaro Kutsuna
Natsumaro Kutsuna
THTatsuhiro Hisatsune
Tatsuhiro Hisatsune
Our goal in this study was to determine whether or not feeding young (4 months old) Alzheimer's disease model transgenic mice with a high fat diet (HFD), consisting of 32% fat, is capable of causing cognitive decline and whether treatment with β-alanyl-L-histidine (carnosine) is capable of reducing these effects. Carnosine is an endogenous antioxidant and antiglycating agent that is abundantly present in the brain and muscle tissues of vertebrates. After 8 weeks of feeding with HFD, we observed a significant decline in the contextual memory in transgenic mice fed with HFD as compared to transgenic mice fed with a normal diet as well as to normal diet-wild type mice. Treatment with carnosine at a dose of 5 mg/day for 6 weeks was effective in preventing cognitive decline, as the transgenic group fed with HFD and treated with carnosine displayed a level of cognition comparable to controls. No differences in senile plaque load were observed between all groups. However, we observed an increase in the expression of RAGE in blood vessels as well as increased microglial activation in the hippocampus of animals fed with HFD, effects that were reversed when treated with carnosine. Given these results, there is a possibility that inflammation and cerebrovascular abnormalities might be the cause of cognitive decline in this model.

2 May 2009 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
TPTetsadê C. B. Piermartiri
Tetsadê C. B. Piermartiri
SVSamuel Vandresen-Filho
Samuel Vandresen-Filho
BHBruno de Araújo Herculano
Bruno de Araújo Herculano
WMWagner C. Martins
Wagner C. Martins
DDDenis Dal’agnolo
Denis Dal’agnolo
Carla Ines TascaCarla Ines Tasca
Carla Ines Tasca

6 June 2019 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
CVCarles Vilarino-Guell
Carles Vilarino-Guell
AZAlexander Zimprich
Alexander Zimprich
FBfilippo martinelli boneschi
filippo martinelli boneschi
BHBruno Herculano
Bruno Herculano
ZWZhe Wang
Zhe Wang
ASA. Dessa Sadovnick
A. Dessa Sadovnick
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system characterized by myelin loss and neuronal dysfunction. Although the majority of patients do not present familial aggregation, Mendelian forms have been described. We performed whole-exome sequencing analysis in 132 patients from 34 multi-incident families, which nominated likely pathogenic variants for MS in 12 genes of the innate immune system that regulate the transcription and activation of inflammatory mediators. Rare missense or nonsense variants were identified in genes of the fibrinolysis and complement pathways (PLAU, MASP1, C2), inflammasome assembly (NLRP12), Wnt signaling (UBR2, CTNNA3, NFATC2, RNF213), nuclear receptor complexes (NCOA3), and cation channels and exchangers (KCNG4, SLC24A6, SLC8B1). These genes suggest a disruption of interconnected immunological and pro-inflammatory pathways as the initial event in the pathophysiology of familial MS, and provide the molecular and biological rationale for the chronic inflammation, demyelination and neurodegeneration observed in MS patients. Although the majority of patients diagnosed with multiple sclerosis do not have a family history of disease, 13% report having a close relative also diagnosed with multiple sclerosis. In these families, the cause of multiple sclerosis can be largely attributed to a single genetic variant that is transmitted through generations. In this study we analyzed DNA from 132 patients from 34 families, resulting in the identification of 12 rare genetic variants that are largely responsible for the onset of multiple sclerosis in these families. These variants are located in genes implicated in specific immunological pathways, and suggest the biological mechanisms that trigger the onset of multiple sclerosis. These genes and variants provide the means for the generation of cellular and animal models of human disease, and highlight biological targets for the development of novel treatments.

21 April 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XSXiulian Sun
Xiulian Sun
YWYili Wu
Yili Wu
BHBruno Herculano
Bruno Herculano
WSWeihong Song
Weihong Song
Down Syndrome (DS) patients develop characteristic Alzheimer's Disease (AD) neuropathology after their middle age. Prominent neuronal loss has been observed in the cortical regions of AD brains. However, the underlying mechanism leading to this neuronal loss in both DS and AD remains to be elucidated. Calcium overloading and oxidative stress have been implicated in AD pathogenesis. Two major isoforms of regulator of calcineurin 1 (RCAN1), RCAN1.1 and RCAN1.4, are detected in human brains. In this report we defined the transcriptional regulation of RCAN1.1 and RCAN1.4 by two alternative promoters. Calcium overloading upregulated RCAN1.4 expression by activating RCAN1.4 promoter through calcineurin-NFAT signaling pathway, thus forming a negative feedback loop in isoform 4 regulation. Furthermore, RCAN1.4 overexpression exacerbated calcium overloading-induced neuronal apoptosis, which was mediated by caspase-3 apoptotic pathway. Our results suggest that downregulating RCAN1.4 expression in neurons could be beneficial to AD patients.

1 May 2011 in Behavioural Brain Research
Verified
Journal Article
Closed access
BHBruno de Araújo Herculano
Bruno de Araújo Herculano
SVSamuel Vandresen-Filho
Samuel Vandresen-Filho
WMWagner Carbolin Martins
Wagner Carbolin Martins
CBCARINA BOECK
CARINA BOECK
Carla Ines TascaCarla Ines Tasca
Carla Ines Tasca

8 December 2009 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
TCTayana Costa
Tayana Costa
LCLeandra C. Constantino
Leandra C. Constantino
BMBruna P. Mendonça
Bruna P. Mendonça
JPJosimar G. Pereira
Josimar G. Pereira
BHBruno Herculano
Bruno Herculano
CBCARINA BOECK
CARINA BOECK